Some considerations on target estimands for health technology assessment.
作者信息
Remiro-Azócar Antonio
机构信息
Medical Affairs Statistics, Bayer plc, Reading, UK.
出版信息
Stat Med. 2022 Dec 10;41(28):5592-5596. doi: 10.1002/sim.9566.
Abstract
摘要
相似文献
1
Some considerations on target estimands for health technology assessment.关于卫生技术评估目标估计量的一些思考。
Stat Med. 2022 Dec 10;41(28):5592-5596. doi: 10.1002/sim.9566.
2
On estimands and the analysis of adverse events in the presence of varying follow-up times within the benefit assessment of therapies.在治疗获益评估中存在不同随访时间情况下的估计量与不良事件分析。
Pharm Stat. 2019 Mar;18(2):166-183. doi: 10.1002/pst.1915. Epub 2018 Nov 20.
3
What matters most? Different stakeholder perspectives on estimands for an invented case study in COPD.最重要的是什么？COPD 虚构病例研究中评价指标的不同利益相关者观点。
Pharm Stat. 2020 Jul;19(4):370-387. doi: 10.1002/pst.1986. Epub 2020 Jan 9.
4
Incorporating estimands into clinical trial statistical analysis plans.将估计量纳入临床试验统计分析计划中。
Clin Trials. 2022 Jun;19(3):285-291. doi: 10.1177/17407745221080463. Epub 2022 Mar 8.
5
Economic analysis of health care technology. A report on principles. Task Force on Principles for Economic Analysis of Health Care Technology.医疗保健技术的经济分析。原则报告。医疗保健技术经济分析原则特别工作组。
Ann Intern Med. 1995 Jul 1;123(1):61-70. doi: 10.7326/0003-4819-123-1-199507010-00011.
6
Estimands: discussion points from the PSI estimands and sensitivity expert group.估计量：来自PSI估计量与敏感性专家组的讨论要点
Pharm Stat. 2017 Jan;16(1):6-11. doi: 10.1002/pst.1745. Epub 2016 Mar 21.
7
Technology assessment in laparoscopic general surgery and gastrointestinal endoscopy: science or convenience?腹腔镜普通外科手术和胃肠内镜检查中的技术评估：是科学还是便利？
Gastroenterology. 1996 Mar;110(3):915-25. doi: 10.1053/gast.1996.v110.pm8608903.
8
Estimands in observational studies: Some considerations beyond ICH E9 (R1).观察性研究中的估计目标：ICH E9（R1）之外的一些考虑因素。
Pharm Stat. 2022 Sep;21(5):835-844. doi: 10.1002/pst.2196. Epub 2022 Feb 6.
9
Study design: statistical and methodologic considerations.研究设计：统计学和方法学考量
Respir Care. 1995 Sep;40(9):980-6.
10
Choosing Estimands in Clinical Trials: Putting the ICH E9(R1) Into Practice.临床试验中的目标选择：实践 ICH E9(R1)。
Ther Innov Regul Sci. 2020 Mar;54(2):324-341. doi: 10.1007/s43441-019-00061-x. Epub 2020 Jan 4.
引用本文的文献
1
A Framework for Reliable, Transparent, and Reproducible Population-Adjusted Indirect Comparisons.一个用于可靠、透明和可重复的人群调整间接比较的框架。
Pharmacoeconomics. 2025 May 5. doi: 10.1007/s40273-025-01503-1.
2
Strengthening health technology assessment for cancer treatments in Europe by integrating causal inference and target trial emulation.通过整合因果推断和目标试验模拟来加强欧洲癌症治疗的卫生技术评估。
Lancet Reg Health Eur. 2025 Apr 9;52:101294. doi: 10.1016/j.lanepe.2025.101294. eCollection 2025 May.
本文引用的文献
1
Discussion of "target estimands for population-adjusted indirect comparisons" by Antonio Remiro-Azocar.安东尼奥·雷米罗-阿佐卡尔所著《人群调整间接比较的目标估计量》的讨论
Stat Med. 2022 Dec 10;41(28):5573-5576. doi: 10.1002/sim.9533.
2
Target estimands for population-adjusted indirect comparisons.人群校正间接比较的目标估计量。
Stat Med. 2022 Dec 10;41(28):5558-5569. doi: 10.1002/sim.9413.
3
Comments on the debate between marginal and conditional estimands.关于边际估计量与条件估计量之间争论的评论
Stat Med. 2022 Dec 10;41(28):5589-5591. doi: 10.1002/sim.9558.
4
Commentary on "Target estimands for population-adjusted indirect comparisons".关于“人群校正间接比较的目标估计量”的评论
Stat Med. 2022 Dec 10;41(28):5570-5572. doi: 10.1002/sim.9517.
5
Conditions for success and margins of error: Estimation in clinical trials.成功的条件与误差范围：临床试验中的估计
Stat Med. 2022 Dec 10;41(28):5586-5588. doi: 10.1002/sim.9497.
6
Parametric G-computation for compatible indirect treatment comparisons with limited individual patient data.适用于有限个体患者数据的兼容间接治疗比较的参数 G 计算。
Res Synth Methods. 2022 Nov;13(6):716-744. doi: 10.1002/jrsm.1565. Epub 2022 May 16.
7
Building HTA insights into the drug development plan: Current approaches to seeking early scientific advice from HTA agencies.将 HTA 洞察融入药物开发计划：寻求 HTA 机构早期科学建议的当前方法。
Drug Discov Today. 2022 Jan;27(1):347-353. doi: 10.1016/j.drudis.2021.09.014. Epub 2021 Sep 28.
8
Causally Interpretable Meta-analysis: Application in Adolescent HIV Prevention.因果可解释的荟萃分析：在青少年艾滋病预防中的应用。
Prev Sci. 2022 Apr;23(3):403-414. doi: 10.1007/s11121-021-01270-3. Epub 2021 Jul 9.
9
Methods for population adjustment with limited access to individual patient data: A review and simulation study.利用有限的个体患者数据进行人群调整的方法：综述和模拟研究。
Res Synth Methods. 2021 Nov;12(6):750-775. doi: 10.1002/jrsm.1511. Epub 2021 Sep 5.
10
Target estimands for efficient decision making: Response to comments on "Assessing the performance of population adjustment methods for anchored indirect comparisons: A simulation study".用于高效决策的目标估计量：对《评估锚定间接比较中总体调整方法的性能：一项模拟研究》评论的回应
Stat Med. 2021 May 20;40(11):2759-2763. doi: 10.1002/sim.8965.
Zotero 插件